BETTER EVIDENCE TO BUILD CONFIDENCE
Abbott provides a robust body of clinical evidence encompassing clinical data and outcomes from tens of thousands of patients across our structural heart portfolio of products.*
IN-DEPTH DATA ABOUT STRUCTURAL HEART PRODUCTS
With our clinical insights and bulletins, you can take a deeper dive into clinical outcomes related to structural heart products. Designed for ease of viewing, these pieces give you a broader perspective about study outcomes, along with product safety and performance.
Transcatheter Valve Solutions
TAVI
Structural Interventions
AMPLATZER™ PFO OCCLUDER
Read morePFO Closure or Medical Therapy in Patients with PFO and Cryptogenic Stroke
AMPLATZER™ PFO OCCLUDER
Read moreEuropean Position Paper on the Management of Patients with Patent Foramen Ovale (PFO)
Amplatzer™ Trevisio™ Intravascular Delivery System
Read moreReal-World Experience with Amplatzer™ Trevisio™ Delivery System
THE INTAGLIO™ WIRE TREATMENT
Read moreAdvantages of the Intaglio™ Wire Treatment of the Amplatzer™ Occluders
AMPLATZER™ PICCOLO OCCLUDER
Read moreUnique Device for Closing PDAs Demonstrates High Levels of Safety and Effectiveness
Surgical Valve Solutions
EPIC™ MITRAL STENTED TISSUE VALVE WITH LINX™ AC TECHNOLOGY
Read more
Epic Mitral – Ten Year Clinical Outcomes of SMVR in a Medicare Population1EPIC™ SUPRA AORTIC STENTED TISSUE VALVE WITH LINX™ AC TECHNOLOGY
Read moreTen-Years Outcomes of a Contemporary Supra-Annular Porcine Aortic Bioprosthesis in a Medicare Population1
EPIC™ MITRAL AND EPIC™ SUPRA STENTED TISSUE VALVES
Read more
Three-Year Outcomes of Valve-in-Valve Intervention within the Epic Supra and Epic Mitral Valves in a Medicare PopulationEPIC™ MITRAL STENTED TISSUE VALVE WITH LINX™ AC TECHNOLOGY
Read moreEpic Mitral Continues the Biocor Legacy: Strength of Design, Tested Over 35 Years2
CLINICAL DATA | TRANSCATHETER VALVE SOLUTIONS
CLINICAL DATA | TAVI
CLINICAL DATA | SURGICAL VALVE SOLUTIONS
CLINICAL DATA | STRUCTURAL INTERVENTIONS
MAT-2004712 v9.0 | Item approved for OUS use only.